483
Matheson Tri-Gas, IncMatheson Tri-Gas, Inc – FDA 483, Dec 9, 2022
Record Details
An FDA inspection of Matheson Tri-Gas, Inc. in Dallas, TX, a medical gas manufacturer, revealed a significant lapse in quality control. The firm failed to conduct annual product reviews for all trans-filled drug products, including Oxygen, USP, Carbon Dioxide, USP, Nitrogen, NF, and Nitrous Oxide, USP. This indicates a failure to maintain records for evaluating product quality and identifying opportunities for continuous process improvement.
View Company Profile
ID · 18491013-fac8-4b88-8469-9edc1ae5d1ab
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.